Catalytic inhibition of KDM1A in Ewing sarcoma is insufficient as a therapeutic strategy
出版年份 2019 全文链接
标题
Catalytic inhibition of KDM1A in Ewing sarcoma is insufficient as a therapeutic strategy
作者
关键词
-
出版物
PEDIATRIC BLOOD & CANCER
Volume 66, Issue 9, Pages e27888
出版商
Wiley
发表日期
2019-06-18
DOI
10.1002/pbc.27888
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia
- (2018) Tamara Maes et al. CANCER CELL
- Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma with SP-2509 engages the endoplasmic reticulum stress response
- (2018) Kathleen I. Pishas et al. MOLECULAR CANCER THERAPEUTICS
- LSD1 activates a lethal prostate cancer gene network independently of its demethylase function
- (2018) Archana Sehrawat et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Enhancer Activation by Pharmacologic Displacement of LSD1 from GFI1 Induces Differentiation in Acute Myeloid Leukemia
- (2018) Alba Maiques-Diaz et al. Cell Reports
- Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning
- (2018) Sigrid A. Langhans Frontiers in Pharmacology
- Ewing sarcoma
- (2018) Thomas G. P. Grünewald et al. Nature Reviews Disease Primers
- Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator
- (2018) Jung Kim et al. Cell Reports
- LSD1: biologic roles and therapeutic targeting
- (2016) Alba Maiques-Diaz et al. Epigenomics
- Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting
- (2016) Emily R. Theisen et al. Oncotarget
- A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC
- (2015) Helai P. Mohammad et al. CANCER CELL
- EWS-FLI1 Utilizes Divergent Chromatin Remodeling Mechanisms to Directly Activate or Repress Enhancer Elements in Ewing Sarcoma
- (2014) Nicolò Riggi et al. CANCER CELL
- Reversible LSD1 Inhibition Interferes with Global EWS/ETS Transcriptional Activity and Impedes Ewing Sarcoma Tumor Growth
- (2014) S. Sankar et al. CLINICAL CANCER RESEARCH
- Reversible Inhibitors of LSD1 as Therapeutic Agents in Acute Myeloid Leukemia: Clinical Significance and Progress to Date
- (2014) Daniel P. Mould et al. MEDICINAL RESEARCH REVIEWS
- Lysine-specific demethylase 1 regulates differentiation onset and migration of trophoblast stem cells
- (2014) Dongmei Zhu et al. Nature Communications
- Development and evaluation of selective, reversible LSD1 inhibitors derived from fragments
- (2013) James R. Hitchin et al. MedChemComm
- The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem Cells
- (2012) William J. Harris et al. CANCER CELL
- Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma
- (2012) Idriss M. Bennani-Baiti et al. HUMAN PATHOLOGY
- EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
- (2012) Michael T. McCabe et al. NATURE
- Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma
- (2012) S Sankar et al. ONCOGENE
- The First European Interdisciplinary Ewing Sarcoma Research Summit
- (2012) Heinrich Kovar et al. Frontiers in Oncology
- Lysine-specific demethylase 1 is highly expressed in solitary fibrous tumors, synovial sarcomas, rhabdomyosarcomas, desmoplastic small round cell tumors, and malignant peripheral nerve sheath tumors
- (2011) Hans-Ulrich Schildhaus et al. HUMAN PATHOLOGY
- LSD1 regulates the balance between self-renewal and differentiation in human embryonic stem cells
- (2011) Antonio Adamo et al. NATURE CELL BIOLOGY
- New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
- (2010) Jonathan B. Baell et al. JOURNAL OF MEDICINAL CHEMISTRY
- LSD1 Is a Subunit of the NuRD Complex and Targets the Metastasis Programs in Breast Cancer
- (2009) Yan Wang et al. CELL
- EWS-FLI-1 Expression Triggers a Ewing's Sarcoma Initiation Program in Primary Human Mesenchymal Stem Cells
- (2008) N. Riggi et al. CANCER RESEARCH
- Microsatellites as EWS/FLI response elements in Ewing's sarcoma
- (2008) K. Gangwal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now